Prevalence of Psychoactive Substance Use During Pregnancy in Argentine Women: A Pilot Study Testing Maternal Hair

Fecha de publicación

2024-06-20T13:10:54Z

2025-05-06T05:10:08Z

2024-05-07

2024-06-20T13:10:59Z

Resumen

The use of psychoactive substances (PSs) during pregnancy is a major public health concern because of their increasing prevalence worldwide. This study examined the understudied issue of gestational PS consumption in a cohort of Argentine delivering mothers.<strong>Methods: </strong>A cross-sectional pilot study involving 51 women receiving delivery care was conducted at the Santa Rosa Hospital in La Pampa, Argentina. Information on maternal sociodemographic characteristics, pregnancy history, and drug use was obtained through standardized interviews. Maternal hair samples were analyzed for alcohol, tobacco, licit, illicit, and prescription substance biomarkers using ultra-high-performance liquid chromatography high-resolution mass spectrometry and gas chromatography mass spectrometry.<strong>Results: </strong>During pregnancy, 49.0% of participants reported alcohol consumption, 25.5% reported tobacco use, and 23.5% reported cannabis use. Hair samples from 56.9% of the women were positive for illicit PSs, with the most frequent being cocaine (41.2%) and cannabis (15.7%). Among the women, 47.1% consumed alcohol during pregnancy. Of the 24 women with hair ethyl glucuronide ≥5 pg/mg, 33.3% drank until the end of gestation and 58.3% started a social drinking habit in the second half. The analysis also detected prescription substances (anticonvulsants, antidepressants, methadone, opioids, antihistamines, antiemetics, and analgesics), caffeine (70.6%), lidocaine, and levamisole, some of which were cocaine or opioid adulterants.<strong>Conclusions: </strong>This is the first study to objectively assess the consumption of licit and illicit PSs during pregnancy in Argentina. In contrast to most nearby countries, cocaine was the most detected illicit PS in this cohort of Argentine delivering women. This finding highlights the importance of regular monitoring of local trends in PS use during pregnancy.

Tipo de documento

Artículo


Versión aceptada

Lengua

Inglés

Publicado por

Wolters Kluwer Health

Documentos relacionados

Versió postprint del document publicat a: https://doi.org/10.1097/FTD.0000000000001218.

Therapeutic Drug Monitoring, 2024

https://doi.org/10.1097/FTD.0000000000001218.

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

(c) International Association of Therapeutic Drug Monitoring and Clinical Toxicology, 2024